Evaluation of NIPSA Using Alloplastic Bone Graft and Cross-Linked Hyaluronic Acid in theTreatment of Intrabony Defects

Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age35-65
SponsorMansoura University

About this trial

Sixty patients will be selected from the outpatient clinic in the Oral Medicine and Periodontology Department, Faculty of Dentistry, Mansoura University, Egypt, according to preoperative clinical and radiographic data that will be used to evaluate the bone destruction pattern.

Eligibility criteria

Qualifiers

Age range: 35 to 65 years old.

Patients diagnosed with stage III. Periodontitis

Presence of isolated intrabony defect with PPD ≥ 6 mm, CAL ≥ 6 mm

Intrabony defect depth ≥3 mm.

Disqualifiers

Smokers ≥ 10 cigarettes per day

Patient with systemic disease.

Pregnant or lactating patients.

Patient who has traumatic occlusion.

Trial design

Treatments tested in this trial

  • allopastic bone graft
  • cross-linked hyaluronic acid
  • Non-Incised Papillae Surgical Approach

Treatment groups

60 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators